Sleep disturbances and childhood cancer - A tertiary care experience

Kaushik, Prakruthi; Sharma, Sujata; Shah, Nikita; Kutty, Purvi Kadakia; Ghildiyal, Radha

doi:10.1016/j.phoj.2022.05.001

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2,[4][5][6][7] Childhood cancer is associated with a wide range of potential adverse treatment consequences. [8][9][10] The disease has a negative impact on the sleep patterns and sleep quality of the children who are treated. [11][12][13] Reduced sleep quality is a significant negative factor affecting the quality of life in this target group even many years after diagnosis and treatment.…”

Section: Introductionmentioning

confidence: 99%

Actigraphy-Based Characteristics of Sleep in Paediatric Cancer Patients in Remission and a Comparison with Their Healthy Peers in the Recovery Stay

Vyhlídal¹,

Dygrýn²,

Chmelík³

2022

NSS

View full text Add to dashboard Cite

Background: Previous research has demonstrated that paediatric cancer survivors (PCS) have lower sleep quality than their healthy peers. However, the research to date has focused mainly on self-reported data. Therefore, the aim of this cross-sectional study was to characterise selected sleep parameters in PCS using objective monitoring techniques and to compare them with a control group (CG) of their healthy peers during a structured recovery stay. A specific objective was to characterise sleep with respect to gender, age, and cancer type. Methods: 26 PCS and 38 CG aged 7-15 years participated in the study. Selected sleep indicators (time in bed, total sleep time, sleep efficiency) were objectively assessed with an Actigraph wGT3X-BT accelerometer for 12 days during the recovery stay. Results: No significant differences were found between the PCS and CG groups in terms of the selected sleep parameters. The total time in bed was 543.1 min/day in the PCS and 537.2 min/day in the CG (p=0.91). The total sleep time was 455.3 min/day in the PCS and 457.5 min/day in the CG (p=0.57). Sleep efficiency was 85.3% in the PCS and 86.3% in the CG (p=0.36). Sleep efficiency >85% was achieved by 62% of the PCS (n=16) and 68% of the CG (n=26). There were no significant differences in sleep parameters in terms of variables such as gender, age, or cancer type. Conclusion:The results of our study suggest that -under the same conditions -the PCS did not differ from their healthy peers in terms of the indicators of time in bed, total sleep time, and sleep efficiency. No significant differences according to age, gender, or cancer type were found.

show abstract